Skip to main content

BARCLAYS PLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 312069 LONDON, X0

Position in CRL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$40,526,460
+$28,730,411 QoQ
Shares Held
234,936
+297.3% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Derivatives in CRL

reported options exposure · as of Sep 30, 2023
CallValue
$0
CallShares
0
PutValue
$979,900
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $2,117,156,031 across 34 Diagnostics & Research names. CRL ranks #9 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $40,526,460 234,936
2025-12-31 $11,796,049 59,134
2025-09-30 $23,681,627 151,359
2025-06-30 $27,292,887 179,878
2025-03-31 $18,022,359 119,734
2024-12-31 $23,402,109 126,772
2024-09-30 $25,768,794 130,826
2024-06-30 $34,128,048 165,205
2024-03-31 $30,745,779 113,474
2023-12-31 $39,997,934 169,196
2023-09-30 $979,900 5,000
2023-09-30 $36,724,690 187,390
2023-06-30 $31,278,891 148,770
2023-03-31 $9,861,528 48,863
2022-12-31 $14,550,489 66,776
2022-09-30 $14,126,302 71,780
2022-06-30 $27,599,774 128,989
2022-03-31 $32,341,058 113,889
2021-12-31 $31,246,364 82,930
2021-09-30 $31,924,563 77,361
2021-06-30 $24,949,624 67,446
2021-03-31 $3,757,935 12,966
2020-12-31 $337,810 1,352
2020-06-30 $81,944 470